Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Milatuzumab> ?p ?o. }
Showing items 1 to 57 of
57
with 100 items per page.
- Milatuzumab abstract "Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma and other hematological malignancies.This drug was developed by Immunomedics, Inc.It has been linked to doxorubicin to form an antibody-drug conjugate for treatment of relapsed multiple myeloma. A phase I/II clinical trial has started.".
- Milatuzumab atcPrefix "none".
- Milatuzumab casNumber "899796-83-9".
- Milatuzumab fdaUniiCode "2OP4E0GC6V".
- Milatuzumab wikiPageID "19841671".
- Milatuzumab wikiPageRevisionID "545469847".
- Milatuzumab atcPrefix "none".
- Milatuzumab c "6518".
- Milatuzumab casNumber "899796".
- Milatuzumab chemspiderid "NA".
- Milatuzumab h "10066".
- Milatuzumab hasPhotoCollection Milatuzumab.
- Milatuzumab kegg "D08944".
- Milatuzumab mabType "mab".
- Milatuzumab molecularWeight "146.7".
- Milatuzumab n "1758".
- Milatuzumab o "2020".
- Milatuzumab s "40".
- Milatuzumab source "zu/o".
- Milatuzumab target CD74.
- Milatuzumab type "mab".
- Milatuzumab unii "2".
- Milatuzumab verifiedfields "changed".
- Milatuzumab verifiedrevid "458284030".
- Milatuzumab subject Category:Monoclonal_antibodies.
- Milatuzumab type Abstraction100002137.
- Milatuzumab type Antibody115027189.
- Milatuzumab type Chemical114806838.
- Milatuzumab type Compound114818238.
- Milatuzumab type Macromolecule114944888.
- Milatuzumab type Material114580897.
- Milatuzumab type Matter100020827.
- Milatuzumab type Molecule114682133.
- Milatuzumab type MonoclonalAntibodies.
- Milatuzumab type MonoclonalAntibody115029781.
- Milatuzumab type OrganicCompound114727670.
- Milatuzumab type Part113809207.
- Milatuzumab type PhysicalEntity100001930.
- Milatuzumab type Protein114728724.
- Milatuzumab type Relation100031921.
- Milatuzumab type Substance100019613.
- Milatuzumab type Thing100002452.
- Milatuzumab type Unit109465459.
- Milatuzumab type Drug.
- Milatuzumab type DrugProduct.
- Milatuzumab type FunctionalSubstance.
- Milatuzumab comment "Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma and other hematological malignancies.This drug was developed by Immunomedics, Inc.It has been linked to doxorubicin to form an antibody-drug conjugate for treatment of relapsed multiple myeloma. A phase I/II clinical trial has started.".
- Milatuzumab label "Milatuzumab".
- Milatuzumab label "Milatuzumab".
- Milatuzumab label "ميلاتوزوماب".
- Milatuzumab sameAs Milatuzumab.
- Milatuzumab sameAs m.04q72w_.
- Milatuzumab sameAs Q3857819.
- Milatuzumab sameAs Q3857819.
- Milatuzumab sameAs Milatuzumab.
- Milatuzumab wasDerivedFrom Milatuzumab?oldid=545469847.
- Milatuzumab isPrimaryTopicOf Milatuzumab.